共 20 条
- [2] Response to Letters Regarding Article, "Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy" CIRCULATION, 2008, 118 (25) : E840 - E841
- [3] Letter by Joshi Regarding Article, "Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy" CIRCULATION, 2008, 118 (25) : 2883 - 2883
- [4] Letter by Tarantini et al Regarding Article, "Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy" CIRCULATION, 2008, 118 (25) : E839 - E839
- [7] Impact of an Initial Strategy of Medical Therapy Without Percutaneous Coronary Intervention in High-Risk Patients From the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (08): : 1055 - 1062
- [8] Optimal Medical Therapy With or Without Percutaneous Coronary Intervention in Older Patients With Stable Coronary Disease A Pre-Specified Subset Analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) Trial JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (14) : 1303 - 1308
- [9] Is there an ischemic threshold beyond which percutaneous coronary intervention is beneficial in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial? AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (09): : 1495 - 1495